Skip to main content

Advertisement

SpringerLink
Log in

Incidental Gastrointestinal Stromal Tumors (GISTs) and Bariatric Surgery: A Review

  • Review
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

The number of bariatric procedures has increased notably, with incidental findings such as gastrointestinal stromal tumors (GISTs) being observed in 2%. The number of studies dealing with incidental findings during bariatric surgery (BS), especially GISTs, is scarce. This review aims to summarize the evidence about GIST diagnosis during BS, and to establish recommendations for the management and follow-up of these patients. A systematic literature search from January 2000 to March 2020 was performed. Retrospective cohort studies, case series, case reports, reviews, and conference abstracts were considered eligible. The present systematic review focused on a descriptive analysis of the data included in the articles selected. The calculated incidence was 0.65%. A change in operative plan was observed in 5% of the cases. In 98% of the cases, GISTs were gastric, with a mean size of 10.3 mm. The mitotic index was < 5 in 99%. Accordingly, all patients were classified as having a very low or low risk of recurrence. R0 resection was achieved in 100% of cases. The incidence of GISTs in patients with MO submitted to BS is considerably higher than in the general population. The diagnosis is related to the depth of preoperative work, the exhaustiveness of the intraoperative examination, and the meticulousness of the histopathological analysis. Although GISTs have a low risk of recurrence and it was previously unnecessary to modify the surgical technique, we recommend that bariatric surgeons are aware of the diagnosis and management of incidental GISTs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Trust for America’s Health. The State of Obesity: Better Policies for a Healthier America. With Special Feature on Racial and Ethnic Disparities in Obesity and Advancing Health Equity. Issue Report. Sept 2019. Available at: https://media.stateofobesity.org/wp- content/uploads/2019/09/16100613/2019ObesityReportFINAL.pdf. Accessed March 2020.

  2. Sjöström L, Lindroos AK, Peltonen M, et al. Et al; Swedish obese subjects study scientific group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.

    Article  PubMed  Google Scholar 

  3. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37. Review. Erratum in: JAMA. 2005 Apr 13;293(14):1728

    Article  CAS  PubMed  Google Scholar 

  4. IFSO Global Registry. Available at: https://www.ifso.com/pdf/5th-ifso-global-registry-report-september-2019.pdf. Accessed in March 2020.

  5. Lyros O, Moulla Y, Mehdorn M, et al. Coincidental detection of gastrointestinal stromal tumors during laparoscopic bariatric procedures—data and treatment strategy of a German reference center. Obes Surg. 2019;29(6):1858–66.

    Article  PubMed  Google Scholar 

  6. Raghavendra RS, Kini D. Benign, premalignant, and malignant lesions encountered in bariatric surgery. JSLS. 2012;16(3):360–72.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Parab TM, DeRogatis MJ, Boaz AM, et al. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019;10(1):144–54.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Mendes JT, Wilson C, Schammel CMG, et al. GIST identified during bariatric surgery: to treat or not to treat? Surg Obes Relat Dis. 2020;16(2):282–7.

    Article  PubMed  Google Scholar 

  10. Cazzo E, de Almeida de Saito HP, Pareja JC, et al. Gastric mesenchymal tumors as incidental findings during roux-en-Y gastric bypass. Surg Obes Relat Dis. 2018;14(1):23–8.

    Article  PubMed  Google Scholar 

  11. Luna C, Luna R, Cabrera LF, et al. Manejo de los tumores del estroma gastrointestinal encontrados en cirugía bariátrica: un desafío quirúrgico. Rev Colom Cir. 2018;33:173–80.

    Article  Google Scholar 

  12. Chiappetta S, Stier C, Weiner RA. Invited response letter: "Gastrointestinal stromal tumor after laparoscopic sleeve gastrectomy: be awake before, during, and after a bariatric procedure". Obes Surg. 2018;28(7):2048–9.

    Article  PubMed  Google Scholar 

  13. Johanet H, Mantilla-Sylvain F, Dabrowski A, et al. Our experience regarding the association between gastrointestinal stromal tumor and bariatric surgery: a response to a letter "Gastrointestinal stromal tumor after laparoscopic sleeve gastrectomy: be awake before, during, and after a bariatric procedure". Obes Surg. 2019;29(2):642–4.

    Article  PubMed  Google Scholar 

  14. Sterbis E, Baker J, Rosenbluth A, Buwen J, Beekley AC, Tichansky DS, et al. Incidence of gastrointestinal stromal tumors is drastically increased in patients with morbid obesity. J Surg 2016: 110. DOI: https://doi.org/10.29011/2575-9760.000110.

  15. Walędziak M, Różańska-Walędziak A, Kowalewski PK, et al. Bariatric surgery and incidental gastrointestinal stromal tumors—a single-center study: VSJ competition, 1(st) place. Wideochir Inne Tech Maloinwazyjne. 2017;12(3):325–9.

    PubMed  PubMed Central  Google Scholar 

  16. Viscido G, Signorini F, Navarro L, et al. Incidental finding of gastrointestinal stromal tumors during laparoscopic sleeve gastrectomy in obese patients. Obes Surg. 2017;27(8):2022–5.

    Article  PubMed  Google Scholar 

  17. Crouthamel MR, Kaufman JA, Billing JP, et al. Incidental gastric mesenchymal tumors identified during laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2015;11(5):1025–8.

    Article  PubMed  Google Scholar 

  18. Chiappetta S, Theodoridou S, Stier C, et al. Incidental finding of GIST during obesity surgery. Obes Surg. 2015;25(3):579–83.

    Article  PubMed  Google Scholar 

  19. Yuval JB, Khalaileh A, Abu-Gazala M, et al. The true incidence of gastric GIST—a study based on morbidly obese patients undergoing sleeve gastrectomy. Obes Surg. 2014;24(12):2134–7.

    Article  PubMed  Google Scholar 

  20. Sanchez BR, Morton JM, Curet MJ, et al. Incidental finding of gastrointestinal stromal tumors (GISTs) during laparoscopic gastric bypass. Obes Surg. 2005;15(10):1384–8.

    Article  PubMed  Google Scholar 

  21. Joo P, Guilbert L, Sepúlveda EM, et al. Unexpected intraoperative findings, situations, and complications in bariatric surgery. Obes Surg. 2019;29(4):1281–6.

    Article  PubMed  Google Scholar 

  22. Ge L, Moon RC, Nguyen H, et al. Pathologic findings of the removed stomach during sleeve gastrectomy. Surg Endosc. 2019;33(12):4003–7.

    Article  PubMed  Google Scholar 

  23. Canil AM, Iossa A, Termine P, et al. Histopathology findings in patients undergoing laparoscopic sleeve gastrectomy. Obes Surg. 2018;28(6):1760–5.

    Article  PubMed  Google Scholar 

  24. Yardimci E, Bozkurt S, Baskoy L, et al. Rare entities of histopathological findings in 755 sleeve gastrectomy cases: a synopsis of preoperative endoscopy findings and histological evaluation of the specimen. Obes Surg. 2018;28(5):1289–95.

    Article  PubMed  Google Scholar 

  25. Dogan U, Suren D, Oruc MT, et al. Spectrum of gastric histopathologies in morbidly obese Turkish patients undergoing laparoscopic sleeve gastrectomy. Eur Rev Med Pharmacol Sci. 2017;21(23):5430–6.

    CAS  PubMed  Google Scholar 

  26. Safaan T, Bashah M, El Ansari W, et al. Histopathological changes in laparoscopic sleeve gastrectomy specimens: prevalence, risk factors, and value of routine histopathologic examination. Obes Surg. 2017;27(7):1741–9. Erratum in: Obes Surg. 2017: Oct;27(10):2778

    Article  PubMed  PubMed Central  Google Scholar 

  27. Kopach P, Genega EM, Shah SN, et al. The significance of histologic examination of gastrectomy specimens: a clinicopathologic study of 511 cases. Surg Obes Relat Dis. 2017;13(3):463–7.

    Article  PubMed  Google Scholar 

  28. Lauti M, Gormack SE, Thomas JM, et al. What does the excised stomach from sleeve gastrectomy tell us? Obes Surg. 2016;26(4):839–42.

    Article  PubMed  Google Scholar 

  29. Miller GC, Reid AS, Brown IS. The pathological findings seen in laparoscopic sleeve gastrectomies for weight loss. Pathology. 2016;48(3):228–32.

    Article  PubMed  Google Scholar 

  30. Kinsinger LA, Garber JC, Whipple O. A review of sleeve gastrectomy specimen histopathology. Am Surg. 2016;82(11):1101–4.

    Article  PubMed  Google Scholar 

  31. Ohanessian SE, Rogers AM, Karamchandani DM. Spectrum of gastric histopathologies in severely obese American patients undergoing sleeve gastrectomy. Obes Surg. 2016;26(3):595–602.

    Article  PubMed  Google Scholar 

  32. Almazeedi S, Al-Sabah S, Al-Mulla A, et al. Gastric histopathologies in patients undergoing laparoscopic sleeve gastrectomies. Obes Surg. 2013;23(3):314–9.

    Article  PubMed  Google Scholar 

  33. Finnell CW, Madan AK, Ternovits CA, et al. Unexpected pathology during laparoscopic bariatric surgery. Surg Endosc. 2007;21(6):867–9.

    Article  CAS  PubMed  Google Scholar 

  34. Greenbaum D, Friedel D. Unanticipated findings at bariatric surgery. Surg Obes Relat Dis. 2005;1(1):22–4.

    Article  PubMed  Google Scholar 

  35. Çaynak M, Özcan B. Laparoscopic transgastric resection of a gastrointestinal stromal tumor and concomitant sleeve gastrectomy: a case report. Obes Surg. 2020; https://doi.org/10.1007/s11695-020-04472-w.

  36. Ayoub K, Danial AK, Sankari Tarabishi A, et al. A rare case of incidental finding of GIST during sleeve gastrectomy: case report. Int J Surg Case Rep. 2019;65:161–3.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Sawalmeh H, Makhdoom M, Khammas A, et al. Incidental finding of gastrointestinal stromal tumors (GISTs) during laparoscopic sleeve gastrectomy. Pulsus J Surg Res. 2019;3(1):87–9.

    Google Scholar 

  38. Bilecik T, Karateke F, Cetinkunar S, et al. Gastrointestinal stromal tumor after laparoscopic sleeve gastrectomy: be awake before, during, and after a bariatric procedure. Obes Surg. 2018;28(6):1785–6.

    Article  PubMed  Google Scholar 

  39. Gorecki PJ. Laparoscopic sleeve gastrectomy for the management of gastric gastrointestinal stromal tumors: a case report and a new concept. EC Gastroenterol Dig Syst. 2018;5(6):430–6.

    Google Scholar 

  40. Dogan U, Oruc MT, Oner OZ, et al. Treatment of gastric gastrointestinal stromal tumor by laparoscopic sleeve gastrectomy in a morbidly obese patient. J Turgut Ozal Med Cent. 2018;25(1):165–6.

    Google Scholar 

  41. Saurabh S. Gastrointestinal stromal tumor: an incidental finding during laparoscopic bariatric surgery. Clin Case Rep. 2017;5(11):1905–6.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Al-Zetawi M, Shabani H, Al Sawalhi S. Is it feasible to concomitantly resect gastric gastrointestinal stromal tumor during bariatric laparoscopic sleeve gastrectomy? Ann Clin Case Rep. 2017;2:1346.

    Google Scholar 

  43. Al-Amode MA. Incidental gastrointestinal stromal tumor discovered after laparoscopic sleeve gastrectomy. Med J Cairo Univ. 2017;85(3):1169–72.

    Google Scholar 

  44. Atas H, Bulus H, Akkurt G, et al. How to approach incidentally detected gastrointestinal stromal tumor during laparoscopic sleeve gastrectomy: a report of two cases. Euroasian J Hepatogastroenterol. 2016;6(2):173–5.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Nickel F, Probst P, Fischer L. Would you unblind the patient? A case of incidental T1 N0 R0 GIST in a randomized controlled trial of sleeve gastrectomy versus roux-en-Y gastric bypass for morbid obesity. Surg Obes Relat Dis. 2016;12:e83–5.

    Article  PubMed  Google Scholar 

  46. de Barros F, Nahoum GP, de Almeida BJ. Treatment of gastrointestinal stromal tumor (GIST) during bariatric surgery. Rev Col Bras Cir. 2015;42(1):67–8.

    Article  PubMed  Google Scholar 

  47. Roshanravan R, Mina HE, Moslemi S, et al. Gastric gastrointestinal stromal tumor (GIST) incidentally found after laparoscopic sleeve gastrectomy: a case report. Ann Colorectal Res. 2014;2:1–3.

    Article  Google Scholar 

  48. Leuratti L, Alfa-Wali M, Bonanomi G. Intraoperative findings during a gastric bypass necessitating the removal of the gastric remnant. To proceed or not with the elective plan? Surg Obes Relat Dis. 2013;9(5):e69–71.

    Article  PubMed  Google Scholar 

  49. Wang Y, Liu J. Laparoscopic sleeve gastrectomy in the treatment of gastrointestinal stromal tumors in morbid obese patients. BMJ Case Rep 2009;2009.

  50. Beltran MA, Pujado B, Méndez PE, et al. Gastric gastrointestinal stromal tumor (GIST) incidentally found and resected during laparoscopic sleeve gastrectomy. Obes Surg. 2010;20(3):393–6.

    Article  PubMed  Google Scholar 

  51. de Roover A, Detry O, de Leval L, et al. Report of two cases of gastric cancer after bariatric surgery: lymphoma of the bypassed stomach after roux-en-Y gastric bypass and gastrointestinal stromal tumor (GIST) after vertical banded gastroplasty. Obes Surg. 2006;16(7):928–31.

    Article  PubMed  Google Scholar 

  52. Abellán I, Ruíz de Angulo D, Parrilla P. Incidental gastric gastrointestinal stromal tumor (GIST) in the excluded stomach after roux-en-Y gastric bypass: a case report and review of the literature. Surg Obes Relat Dis. 2014;10(1):e13–4.

    Article  PubMed  Google Scholar 

  53. Fernández JA, Frutos MD, Ruiz-Manzanera JJ, et al. Gastrointestinal stromal tumors after laparoscopic gastric bypass for morbid obesity: a diagnostic and therapeutic challenge. Obes Surg. 2019;29(8):2618–21.

    Article  PubMed  Google Scholar 

  54. Sandvik OM, Søreide K, Kvaløy JT, et al. Epidemiology of gastrointestinal stromal tumors: single-institution experience and clinical presentation over three decades. Cancer Epidemiol. 2011;35(6):515–20.

    Article  PubMed  Google Scholar 

  55. Ma GL, Murphy JD, Martinez ME, et al. Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study. Cancer Epidemiol Biomark Prev. 2015;24(1):298–302.

    Article  Google Scholar 

  56. Søreide K, Sandvik OM, Søreide JA, et al. Global epidemiology of gastrointestinal stromal tumors (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46.

    Article  PubMed  Google Scholar 

  57. Gagner M. Comment on: gastric mesenchymal tumors as incidental findings during roux-en-Y gastric bypass. Surg Obes Relat Dis. 2018;14(1):28–9.

    Article  PubMed  Google Scholar 

  58. Kawanowa K, Sakuma Y, Sakurai S, et al. High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol. 2006;37(12):1527–35.

    Article  PubMed  Google Scholar 

  59. Chan CHF, Cools-Lartigue J, Feldman LS, et al. The impact of incidental gastrointestinal stromal tumors on patients undergoing resection of upper gastrointestinal neoplasms. Can J Surg. 2012;55(6):366–70.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Yuval JB, Elazary R. The true incidence of gastric GIST: an update. Obes Surg. 2018;28(6):1787.

    Article  PubMed  Google Scholar 

  61. Berger NA. Obesity and cancer pathogenesis. Ann N Y Acad Sci. 2014;1311:57–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Safaan T, El Ansari W, Bashah M. Compared to what? Is BMI associated with histopathological changes in laparoscopic sleeve gastrectomy specimens? Obes Surg. 2019;29(7):2166–73.

    Article  Google Scholar 

  63. Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008;39:1411–9.

    Article  PubMed  Google Scholar 

  64. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23(2):70–83.

    Article  PubMed  Google Scholar 

  65. Coe TM, Fero KE, Fanta PT, et al. Population-based epidemiology and mortality of small malignant gastrointestinal stromal tumors in the USA. J Gastrointest Surg. 2016;20(6):1132–40.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Stiles ZE, Rist TM, Dickson PV, et al. Impact of body mass index on the short-term outcomes of resected gastrointestinal stromal tumors. J Surg Res. 2017;217:123–30.

    Article  PubMed  Google Scholar 

  67. SAGES Guidelines Committee. SAGES guidelines for clinical application of laparoscopic bariatric surgery. Surg Endosc. 2008;22(10):2281–300.

    Article  Google Scholar 

  68. Schreiner MA. Endoscopy in the obese patient. Gastroenterology Clinics of NA Elsevier Ltd; 2010;39(1):87–97.

  69. Endo Y, Ohta M, Tada K, et al. Clinical significance of upper gastrointestinal endoscopy before laparoscopic bariatric procedures in Japanese patients. Surg Today. 2019;49(1):27–31.

    Article  PubMed  Google Scholar 

  70. D'Silva M, Bhasker AG, Kantharia NS, et al. High-percentage pathological findings in obese patients suggest that esophago-gastro-duodenoscopy should be made mandatory prior to bariatric surgery. Obes Surg. 2018;28(9):2753–9.

    Article  PubMed  Google Scholar 

  71. Zeni TM, Frantzides CT, Mahr C, et al. Value of preoperative upper endoscopy in patients undergoing laparoscopic gastric bypass. Obes Surg. 2006;16(2):142–6.

    Article  PubMed  Google Scholar 

  72. Saarinen T, Kettunen U, Pietiläinen KH, et al. Is preoperative gastroscopy necessary before sleeve gastrectomy and roux-en-Y gastric bypass? Surg Obes Relat Dis. 2018;14(6):757–62.

    Article  PubMed  Google Scholar 

  73. Wolter S, Duprée A, Miro J, et al. Upper gastrointestinal endoscopy prior to bariatric surgery—mandatory or expendable? An analysis of 801 cases. Obes Surg. 2017;27(8):1938–43.

    Article  PubMed  Google Scholar 

  74. Hansen SK, Pottorf BJ, Hollis Jr HW, et al. Is it necessary to perform full pathologic review of all gastric remnants following sleeve gastrectomy? Am J Surg. 2017;214(6):1151–5.

    Article  CAS  PubMed  Google Scholar 

  75. AbdullGaffar B, Raman L, Khamas A, et al. Should we abandon routine microscopic examination in bariatric sleeve gastrectomy specimens? Obes Surg. 2016;26(1):105–10.

    Article  PubMed  Google Scholar 

  76. Walędziak M, Różańska-Walędziak A, Janik MR, et al. Macroscopic evaluation of gastric specimens after laparoscopic sleeve gastrectomy-an optimum screening test for incidental pathologies? Obes Surg. 2019;29(1):28–31.

    Article  PubMed  Google Scholar 

  77. Demetri GD, Benjamin RS, Blanke CD, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines. J Natl Compr Cancer Netw. 2007;5(Suppl 2):S1–29. quiz S30. Review. Erratum in: J Natl Compr Canc Netw. 2007 Aug;5(7):xxx

    Google Scholar 

  78. Casali PG, Abecassis N, Bauer S, et al. Gastrointestinal stromal tumors: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv68–78.

    Article  CAS  PubMed  Google Scholar 

  79. Rebibo L, Hakim S, Dhahri A, et al. Gastric stenosis after laparoscopic sleeve gastrectomy: diagnosis and management. Obes Surg. 2016;26(5):995–1001.

    Article  PubMed  Google Scholar 

  80. Chang PC, Tai CM, Hsin MC, et al. Surgical standardization to prevent gastric stenosis after laparoscopic sleeve gastrectomy: a case series. Surg Obes Relat Dis. 2017;13(3):385–90.

    Article  PubMed  Google Scholar 

  81. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279(5350):577–80.

    Article  CAS  PubMed  Google Scholar 

  82. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299(5607):708–10.

    Article  CAS  PubMed  Google Scholar 

  83. Tuveson DA, Willis NA, Jacks T, et al. STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications. Oncogene. 2001;20:5054–8.

    Article  CAS  PubMed  Google Scholar 

  84. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med. 2001;344(14):1052–6.

    Article  CAS  PubMed  Google Scholar 

  85. DeMatteo RP, Ballman KV, Antonescu CR, et al. American College of Surgeons Oncology Group (ACOSOG) intergroup adjuvant GIST study team for the Alliance for Clinical Trials in Oncology. Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial. Ann Surg. 2013;258(3):422–9.

    Article  PubMed  Google Scholar 

  86. Dematteo RP, Ballman KV, Antonescu CR, et al. American College of Surgeons Oncology Group (ACOSOG) intergroup adjuvant GIST study team. Adjuvant imatinib mesylate after resection of localized, primary gastrointestinal stromal tumor: a randomized, double-blind, placebo-controlled trial. Lancet. 2009;373(9669):1097–104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Joensuu H, Eriksson M, Sundby Hall K, et al. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012;307(12):1265–72.

    Article  CAS  PubMed  Google Scholar 

  88. Yoo C, Ryu MH, Kang BW, et al. Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinib. J Clin Oncol. 2010;28:1554–9.

    Article  CAS  PubMed  Google Scholar 

  89. Pavlovsky C, Egorin MJ, Shah DD, et al. Imatinib mesylate pharmacokinetics before and after sleeve gastrectomy in a morbidly obese patient with chronic myeloid leukemia. Pharmacotherapy. 2009;29(9):1152–6.

    Article  CAS  PubMed  Google Scholar 

  90. Bouchet S, Poulette S, Titier K, et al. Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumors in a real-life setting. Eur J Cancer. 2016;57:31–8.

    Article  CAS  PubMed  Google Scholar 

  91. Demetri GD, Wang Y, Wehrle E, et al. Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors. J Clin Oncol. 2009;27:3141–7.

    Article  CAS  PubMed  Google Scholar 

  92. Joensuu H, Martín-Broto J, Nishida T, et al. Follow-up strategies for patients with gastrointestinal stromal tumor treated with or without adjuvant imatinib after surgery. Eur J Cancer. 2015;51:1611–7.

    Article  CAS  PubMed  Google Scholar 

  93. Novitsky YW, Kercher KW, Sing RF, et al. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg. 2006;243(6):738–45. discussion 745-7

    Article  PubMed  PubMed Central  Google Scholar 

  94. Wiggins T, Antonowicz SS, Markar SR. Cancer risk following bariatric surgery—systematic review and meta-analysis of national population-based cohort studies. Obes Surg. 2019;29(3):1031–9.

    Article  PubMed  Google Scholar 

  95. Schauer DP, Feigelson HS, Koebnick C, et al. Association between weight loss and the risk of cancer after bariatric surgery. Obesity (Silver Spring). 2017;25(Suppl 2):S52–7.

    Google Scholar 

  96. Scozzari G, Trapani R, Toppino M, et al. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42.

    Article  PubMed  Google Scholar 

  97. Musella M, Berardi G, Bocchetti A, et al. Esophagogastric neoplasms following bariatric surgery: an updated systematic review. Obes Surg. 2019;29(8):2660–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sarcoma and Mesenchymal Tumors Unit, General Surgery Service, “La Arrixaca” Clinical University Hospital, Murcia, Spain

    J. A. Fernández

  2. Bariatric Surgery Unit, General Surgery Service, “La Arrixaca” Clinical University Hospital, Murcia, Spain

    M. D. Frutos

  3. General Surgery Service, “La Arrixaca” Clinical University Hospital, Murcia, Spain

    J. J. Ruiz-Manzanera

Authors
  1. J. A. Fernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. D. Frutos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. J. Ruiz-Manzanera
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. A. Fernández.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Declaration of ethical approval

All of the procedures carried out in studies with human participants were in accordance with the ethical standards of the institutional and/or national research committee and the Declaration of Helsinki of 1964 and its subsequent modifications or comparable ethical standards.

Declaration of informed consent

For this type of study, formal consent is not required.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fernández, J.A., Frutos, M.D. & Ruiz-Manzanera, J.J. Incidental Gastrointestinal Stromal Tumors (GISTs) and Bariatric Surgery: A Review. OBES SURG 30, 4529–4541 (2020). https://doi.org/10.1007/s11695-020-04853-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-020-04853-1

Keywords

Search

Navigation